期刊文献+

趋化因子CCL15在肝癌患者血清中的表达及其临床意义 被引量:2

原文传递
导出
摘要 我们的前期研究显示,趋化因子CCL15在未经治疗的肝癌(HCC)患者血清中高表达,在经介入治疗的HCC患者低表达,在正常人血清中几乎不表达。这提示CCL15与HCC密切相关。鉴于目前国内外尚无有关HCC患者血清CCL15表达的文献报道。我们应用酶联免疫吸附试验(ELISA)法进一步研究HCC血清中CCL15的表达水平及其临床意义。
作者 周伟 李悦国
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第11期780-782,共3页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(81101754)
  • 相关文献

参考文献10

  • 1Scotton C, Milliken D, Wilson J, et al. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours [J]. Br J Cancer, 2001,85(6) :891-897.
  • 2许文犁,谭晓宇,张爱群,李崇辉,董家鸿.肝硬化环境下黏附分子表达对肝癌转移的影响[J].中华肝胆外科杂志,2013,19(6):441-446. 被引量:4
  • 3Moil K, Chano T, Yamamoto K, et al. Expression of macrophage inflammatory protein-1 alpha in Sehwann cell tumors[ J]. Neuropa- thology, 2004,4(2) :131-135.
  • 4Vande Broek I, Leleu X, Schots R, et al. Clinical significance of ehemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival[ J ]. Haematologica, 2006,91 (2) :200-206.
  • 5Sung H J, Kim YS, Kang H, et al. Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte ehemoattractam protein l/CCL2-induced cell mitgation [J]. Exp Mol Med, 2008,40(3):332-338.
  • 6郝保兵,饶建华,吕凌,张峰.胆汁酸膜受体TGR5在肝脏代谢免疫中的研究进展[J].中华肝胆外科杂志,2014,20(11):834-837. 被引量:2
  • 7Reckamp KL, Gardner BK, Figlin RA, et al. Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin[J]. J Thorac Oncol, 2008,3(2) :117-124.
  • 8李悦国,张宁.趋化因子CCL15在肝细胞肝癌组织中的表达及其临床意义[J].中国肿瘤临床,2011,38(2):87-88. 被引量:4
  • 9Ko J, Kim IS, Jang SW, et al. Leukotactin-1/CCL15-induced ehernotaxis signaling through CCR1 in HOS cells~ J]. FEBS Lett, 2002,515 ( 1-3 ) : 159-164.
  • 10Lee JS, Kim IS. Leukotactin-1/CCLl5 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation [ J ]. Mol Biol Rep, 2010, 37 ( 5 ) : 2149-2156.

二级参考文献39

  • 1姜晗昉,任军,崔勇,张晓鹏.小鼠原位移植性肝癌模型的建立及其磁共振表现[J].现代肿瘤医学,2007,15(2):174-176. 被引量:6
  • 2Ou DL,Chen CL,Lin SB,et al.Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy[J].J Pathol,2006,210(3):363-373.
  • 3Mori K,Chano T,Yamamoto K,et al.Expression of macrophage inflammatory protein-lalpha in Schwann cell tumors[J].Neuropa-thology,2004,24(2):131-135.
  • 4Vande Broek I,Leleu X,Schots R,et al.Clinical significance of chemokine receptor (CCR1,CCR2 and CXCR4) expression in human myeloma cells:the association with disease activity and surviv-al[J].Haematologica,2006,91(2):200-206.
  • 5Sung HJ,Kim YS,Kang H,et al.Human LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein 1/CCL2-induced cell migration[J].Exp Mol Med,2008,40(3):332-338.
  • 6Hwang J,Kim CW,Son KN,et al.Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo[J] ,FEBS Lett,2004,570 (1-3):47-51.
  • 7Scotton C,Milliken D,Wilson J,et al.Aanlysis of CC chemokine and chemokine receptor expression in solid ovarian tumours[J].Br J Cancer,2001,85(6):891-897.
  • 8Reckamp KL,Gardner BK,Figlin RA,et al.Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin[J].J Thorac Oncol,2008,3(2):117-124.
  • 9Ko J,Kim IS,Jang SW,et al.Leukotactin-1/CCL15-induced che-motaxis signaling through CCR1 in HOS cells[J].FEBS Lett,2002,515(1-3):159-164.
  • 10Lee JS,Kim IS.Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation[J].Mol Biol Rep,2010,37(5):2149-2156.

共引文献7

同被引文献12

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部